Karine Egan
Impact in
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
Papers in
-
- Inflammatory mediators and NSAID effects 7
- Genetics 5
- Estrogen and related hormone effects 5
- Chronic Lymphocytic Leukemia Research 3
- Co-authors
- Garret A. FitzGerald (10 shared papers)John A. Lawson (3 shared papers)Emer M. Smyth (2 shared papers)Daniel J. Rader (2 shared papers)Beverley Koller (2 shared papers)Susanne Fries (2 shared papers)Alicia Zukas (1 shared paper)Ellen Puré (1 shared paper)
- Journals
- Blood (3 papers)Thrombosis Research (1 paper)The Journal of Immunology (1 paper)PLoS Medicine (1 paper)Handbook of experimental pharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Karine Egan
13 papers receiving 876 citations
Peers
Comparison fields: 5 of 84
- Biochemistry 203
- Pharmacology 389
- Cardiology and Cardiovascular Medicine 189
- Endocrinology, Diabetes and Metabolism 112
- Immunology 140
Countries citing papers authored by Karine Egan
This map shows the geographic impact of Karine Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Egan more than expected).
Fields of papers citing papers by Karine Egan
This network shows the impact of papers produced by Karine Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Egan. The network helps show where Karine Egan may publish in the future.
Co-authors
The 25 scholars most cited alongside Karine Egan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 350 | |
| 2 | 2005 | 166 | |
| 3 | 2007 | 133 | |
| 4 | 2005 | 79 | |
| 5 | 2003 | 43 | |
| 6 | 2004 | 40 | |
| 7 | 2006 | 28 | |
| 8 | 2007 | 21 | |
| 9 | 2007 | 15 | |
| 10 | 2009 | 12 | |
| 11 | 2005 | 4 | |
| 12 | 2010 | 4 | |
| 13 | 2011 | 2 |
About Karine Egan
Karine Egan is a scholar working on Pharmacology, Genetics, Genetics, Cardiology and Cardiovascular Medicine and Hematology, having authored 13 papers that have together received 897 indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (7 papers), Estrogen and related hormone effects (5 papers), Chronic Myeloid Leukemia Treatments (3 papers), Chronic Lymphocytic Leukemia Research (3 papers), Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Menopause: Health Impacts and Treatments (2 papers), Eicosanoids and Hypertension Pharmacology (2 papers) and Immune Response and Inflammation (2 papers). The work is most often cited by research in Biochemistry (203 citations), Pharmacology (389 citations), Cardiology and Cardiovascular Medicine (189 citations), Endocrinology, Diabetes and Metabolism (112 citations) and Immunology (140 citations). Karine Egan has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Garret A. FitzGerald, John A. Lawson, Emer M. Smyth, Daniel J. Rader, Beverley Koller, Susanne Fries, Alicia Zukas, Ellen Puré, Margaret B. Lucitt and Miao Wang. Their work appears in journals such as Blood, Thrombosis Research, The Journal of Immunology, PLoS Medicine and Handbook of experimental pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.